#ECOI1922089AOrder of October 14, 2019, on Export and Import Authorization Procedures for Drug Precursors
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This law outlines the procedures for obtaining export and import authorizations for drug precursors in France. Companies dealing with specific categories of substances need prior authorization, and both imports and exports are subject to different forms and documents. The applications must be submitted online and are processed within a 15-day period.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Introduces a formal procedure for export and import authorizations of drug precursors
- Requires online submission for export and import requests
- Specifies a 15-day processing period for applications
Obligations
What this law requires
Companies exporting drug precursors in categories 1, 2, or 4 must obtain prior authorization before export
Companies exporting category 3 substances to specified countries (Article 10, EU Regulation 2015/1011) must obtain prior authorization
Export authorization applications must be submitted online via the TELESCOPE platform and must include: import authorization (if applicable), invoice in French, and any other relevant documents
For simplified authorization requests covering more than 5 exports, companies must provide a provisional export schedule with dates and quantities based on historical data from the preceding 6 or 12 months
Companies importing category 1 substances or mixtures containing category 1 substances from non-EU countries must obtain prior authorization using form Cerfa 12715*02